Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation - results from the Dresden NOAC registry

被引:0
|
作者
Hecker, J. [1 ]
Marten, S. [1 ]
Tittl, L. [1 ]
Beyer-Westendorf, J. [1 ]
机构
[1] Univ Hosp Dresden, Dresden, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O101
引用
收藏
页码:201 / 201
页数:1
相关论文
共 50 条
  • [21] Clinical effectiveness and safety of edoxaban in obese patients-Results of the prospective Dresden NOAC Registry (NCT01588119)
    Tittl, Luise
    Koehler, Christina
    Marten, Sandra
    Naue, Christiane
    Fache, Kristina
    Stannek, Laura
    Schreier, Thomas
    Beyer-Westendorf, Jan
    THROMBOSIS RESEARCH, 2023, 228 : 134 - 136
  • [22] Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
    Beyer-Westendorf, Jan
    Gelbricht, Vera
    Foerster, Kati
    Ebertz, Franziska
    Koehler, Christina
    Werth, Sebastian
    Kuhlisch, Eberhard
    Stange, Thoralf
    Thieme, Christoph
    Daschkow, Katharina
    Weiss, Norbert
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1888 - 1896
  • [23] Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
    Lai, Chao-Lun
    Chen, Ho-Min
    Liao, Min-Tsun
    Lin, Ting-Tse
    Chan, K. Arnold
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):
  • [24] Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
    Melgaard, Line
    Overvad, Thure Filskov
    Jensen, Martin
    Christensen, Thomas Decker
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    Nielsen, Peter Bronnum
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [25] Patterns of VTE treatment with rivaroxaban in cancer patients: results of the prospective Dresden NOAC registry (NCT01588119)
    Michalski, F.
    Ebertz, F.
    Gelbricht, V.
    Foerster, K.
    Thieme, C.
    Tittl, L.
    Koehler, C.
    Werth, S.
    Beyer-Westendorf, J.
    THROMBOSIS RESEARCH, 2014, 133 : S221 - S222
  • [26] Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka - a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)
    Beyer-Westendorf, Jan
    Michalski, Franziska
    Werth, Sebastian
    Tittl, Luise
    Koehler, Christina
    Weiss, Norbert
    BLOOD, 2014, 124 (21)
  • [27] EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Sogaard, Mette
    Larsen, Torben Bjerregaard
    Lip, Greg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 502 - 502
  • [28] Selection, management and outcome of VKA patients with atrial fibrillation not switched to novel oral anticoagulants - results from the Dresden Noac registry (NCT01588119)
    Michalski, F.
    Werth, S.
    Tittl, L.
    Marten, S.
    Weiss, N.
    Beyer-Westendorf, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 492 - 493
  • [29] Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
    Dong, Zhimin
    Hou, Xiaoxia
    Du, Xin
    He, Liu
    Dong, Jianzeng
    Ma, Changsheng
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [30] Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
    Dong, Zhimin
    Hou, Xiaoxia
    Du, Xin
    He, Liu
    Dong, Jianzeng
    Ma, Changsheng
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28